343 related articles for article (PubMed ID: 31621923)
21. Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service.
Charles KS; Hughes P; Gadd R; Bodkyn CJ; Rodriguez M
Transfus Med; 2010 Feb; 20(1):11-4. PubMed ID: 19788640
[TBL] [Abstract][Full Text] [Related]
22. Donor return after temporary deferral.
Custer B; Schlumpf KS; Wright D; Simon TL; Wilkinson S; Ness PM;
Transfusion; 2011 Jun; 51(6):1188-96. PubMed ID: 21155833
[TBL] [Abstract][Full Text] [Related]
23. Pre-donation deferral of blood donors in a Brazilian blood bank: a 10-year experience.
Dias PB; Lissa NM; Skare T; Fávero KB; Almeida PTR; Nisihara R
Transfus Med; 2019 Dec; 29(6):448-453. PubMed ID: 31608541
[TBL] [Abstract][Full Text] [Related]
24. In the Mood for a Blood Donation? Pilot Study about Momentary Mood, Satisfaction, and Return Behavior in Deferred First-Time Donors.
Greffin K; Muehlan H; Tomczyk S; Suemnig A; Schmidt S; Greinacher A
Transfus Med Hemother; 2021 Aug; 48(4):220-227. PubMed ID: 34539315
[TBL] [Abstract][Full Text] [Related]
25. Deferral patterns of voluntary blood donors at the National Blood Transfusion Service, North East Zonal Centre, Maiduguri.
Kagu MB; Ahmed SG; Bashir MA; Malah MB; Usoro A; Gimba I; Babakura Y; Elisha J
Afr J Med Med Sci; 2010 Jun; 39(2):119-25. PubMed ID: 21117408
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and causes of pre-donation deferrals at a Chinese blood center.
Yang Y
Transfus Apher Sci; 2021 Aug; 60(4):103153. PubMed ID: 34016553
[TBL] [Abstract][Full Text] [Related]
27. Predicting hemoglobin levels in whole blood donors using transition models and mixed effects models.
Nasserinejad K; de Kort W; Baart M; Komárek A; van Rosmalen J; Lesaffre E
BMC Med Res Methodol; 2013 May; 13():62. PubMed ID: 23635008
[TBL] [Abstract][Full Text] [Related]
28. Reasons for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast.
Kouao MD; Dembelé B; N'Goran LK; Konaté S; Bloch E; Murphy EL; Lefrère JJ
Transfusion; 2012 Jul; 52(7 Pt 2):1602-6. PubMed ID: 22780941
[TBL] [Abstract][Full Text] [Related]
29. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
Cable R; Musavi F; Notari E; Zou S;
Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania.
Valerian DM; Mauka WI; Kajeguka DC; Mgabo M; Juma A; Baliyima L; Sigalla GN
PLoS One; 2018; 13(10):e0206487. PubMed ID: 30359434
[TBL] [Abstract][Full Text] [Related]
31. Impact of risk-dependent interventions on low haemoglobin deferral rates in whole blood donors.
Baart AM; van den Hurk K; de Kort WLAM; Huis In 't Veld EMJ
Vox Sang; 2020 Apr; 115(3):171-181. PubMed ID: 31912518
[TBL] [Abstract][Full Text] [Related]
32. Whole blood donor return rates after deferral for tattooing or body piercing-Survey across blood donation services: The BEST collaborative study.
Quee F; O'Brien SF; Prinsze F; Steele WR; Grégoire Y; Cutajar A; Wendel S; Compernolle V; Goldman M; van den Hurk K;
Vox Sang; 2022 Sep; 117(9):1085-1089. PubMed ID: 35706056
[TBL] [Abstract][Full Text] [Related]
33. Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period.
Custer B; Schlumpf K; Simon TL; Spencer BR; Wright DJ; Wilkinson SL;
Transfusion; 2012 Apr; 52(4):712-21. PubMed ID: 21950621
[TBL] [Abstract][Full Text] [Related]
34. Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply.
Vinkenoog M; van Leeuwen M; Janssen MP
Vox Sang; 2022 Nov; 117(11):1262-1270. PubMed ID: 36102148
[TBL] [Abstract][Full Text] [Related]
35. No increased risk of transfusion-transmissible infections after tattooing, body piercing, or acupuncture among blood donors in the Netherlands.
Prinsze FJ; van de Laar T; Slot E; de Jong M; Bokhorst A; de Kort W; Zaaijer H; van den Hurk K
Transfusion; 2019 Aug; 59(8):2575-2583. PubMed ID: 31228271
[TBL] [Abstract][Full Text] [Related]
36. Blood Donor Deferral Analysis in Relation to the Screening Process: A Single-Center Study from Southern India with Emphasis on High Hemoglobin Prevalence.
Kandasamy D; Shastry S; Chenna D; Mohan G
J Blood Med; 2020; 11():327-334. PubMed ID: 33061730
[TBL] [Abstract][Full Text] [Related]
37. Frequency and reasons of donor deferral prior to blood donation process: a single centre experience.
Khurram S; Borhany M; Anwar N; Naseer I; Boota S; Mirza I; Nadeem M; Shamsi T
Transfus Med; 2017 Feb; 27(1):10-15. PubMed ID: 27730692
[TBL] [Abstract][Full Text] [Related]
38. Effect of a national disaster on blood supply and safety: the September 11 experience.
Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH;
JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136
[TBL] [Abstract][Full Text] [Related]
39. Educating donors about deferrals through the provision of tailored materials: Findings from a survey of deferred donors.
Gemelli CN; Kruse SP; Thijsen A; Van Dyke N; Davison TE
Transfusion; 2021 Mar; 61(3):822-829. PubMed ID: 33615506
[TBL] [Abstract][Full Text] [Related]
40. Utility of zinc protoporphyrin in management of whole blood donors.
Schotten N; Zalpuri S; Pasker-de Jong PCM; Swinkels DW; van den Hurk K; de Kort WLAM; van Kraaij MGJ; van Noord PAH
Transfusion; 2018 Mar; 58(3):692-700. PubMed ID: 29377138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
